1 Min Read
Dec 18 (Reuters) - Allied Minds Plc:
* POSITIVE TOP-LINE RESULTS OF PHASE 1/2 STUDY OF SF0166 EYE DROPS TO TREAT WET AGE-RELATED MACULAR DEGENERATION Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.